Apellis Highlights Commercial Growth and Strategic Priorities at 43rd Annual J.P. Morgan Healthcare Conference
January 13, 2025 09:00 ET
|
Apellis Pharmaceuticals, Inc.
Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues $611 million in SYFOVRE® U.S. net product revenues, including $167 million in 4Q 2024$98 million in EMPAVELI® U.S. net...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
January 13, 2025 09:00 ET
|
VIVUS LLC
CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing...
Battery Tender Expands Retail Partnership with Costco, Adding EV Chargers to Canadian Online Store
January 13, 2025 09:00 ET
|
Battery Tender
Availability of the chargers on the Costco Canada website is another signal of both companies’ commitment to green technology
Editas Medicine Highlights New In Vivo Preclinical Proof of Concept Data, Anticipated 2025 Key Milestones, and Three-year Strategic Priorities
January 13, 2025 09:00 ET
|
Editas Medicine, Inc.
Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel in vivo treatment for sickle cell disease and beta...
Brunswick Drilling Expanding Lithium Zones on Mirage (Lac Escale) Globex Royalty Claims
January 13, 2025 09:00 ET
|
Globex Mining Enterprises Inc.
ROUYN-NORANDA, Quebec, Jan. 13, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS...
Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12
January 13, 2025 09:00 ET
|
Artelo Biosciences
The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjects Initial safety and pharmacokinetic data expected during the first half 2025 SOLANA BEACH, Calif.,...
Freight Technologies Renews Multi-Year Logistics Services Agreement with Kimberly-Clark de México
January 13, 2025 09:00 ET
|
Freight App, Inc.
HOUSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a logistics management innovation company, offering a diverse portfolio of...
EnerPure Announces Completion of FEL-2 Engineering for Full-Scale Commercial Recycling Plant
January 13, 2025 09:00 ET
|
Enerpure Inc.
Winnipeg, MB, Jan. 13, 2025 (GLOBE NEWSWIRE) -- EnerPure Inc. (“EnerPure” or the “Company”), a recycling and energy transition company, is pleased to announce that it has, with the support of Ascent...
Progress Once Again Honored as a Top Place to Work and Socially Responsible Organization by Prestigious Publications Including The Boston Globe and Newsweek
January 13, 2025 09:00 ET
|
Progress Software Corporation
Company closes 2024 with multiple award recognitions for corporate social responsibility, workplace culture, inclusion and belonging, and more
NeurAxis Inc. Issues Letter to Shareholders
January 13, 2025 09:00 ET
|
NeurAxis, Inc.
CARMEL, Ind., Jan. 13, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing...
- January 14, 2025 05:19 ET Pediatric Cardiac Tumor Diagnostics Market Analysis and Revenue Forecasts to 2034 by Tumor, Type, End User and Region
- January 14, 2025 04:22 ET Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin